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Abstract
Using the complete genome sequences of 19 coronavirus genomes, we analyzed the codon usage bias, dinucleotide relative abundance and cytosine
deamination in coronavirus genomes. Of the eight codons that contain CpG, six were markedly suppressed. The mean NNU/NNC ratio of the six amino
acids using either NNC or NNU as codon is 3.262, suggesting cytosine deamination. Among the 16 dinucleotides, CpGwas most markedly suppressed
(mean relative abundance 0.509). No correlationwas observed betweenCpG abundance andmeanNNU/NNC ratio. Among the 19 coronaviruses, CoV-
HKU1 showed themost extreme codon usage bias and extremely highNNU/NNC ratio of 8.835. Cytosine deamination and selection of CpG suppressed
clones by the immune system are the two major independent biochemical and biological selective forces that shape codon usage bias in coronavirus
genomes. The underlyingmechanism for the extreme codon usage bias, cytosine deamination and G+C content in CoV-HKU1warrants further studies.
© 2007 Elsevier Inc. All rights reserved.Keywords: Coronavirus; Cytosine deamination; CpG suppression; Codon usage biasIntroduction
Codon usage bias is one of the most important indicators of
the selective forces that shape genome evolution. In general,
codon usage bias may be a result of mutation pressure and/or
relative abundance of the corresponding acceptor tRNA
molecules. For human RNA viruses, it has been observed in
one study that codon usage bias was related tomutation pressure,
G+C content, segmented nature of the genome and the route of
transmission of the virus (Jenkins and Holmes, 2003). In other
studies, it has been suggested that mutation pressure may result
in bias in dinucleotide usage, such as CpG suppression, in small
eukaryotic viruses (Karlin et al., 1994; Shackelton et al., 2006).⁎ Corresponding author. State Key Laboratory of Emerging Infectious
Diseases, Department of Microbiology, The University of Hong Kong, Room
423, University Pathology Building, Queen Mary Hospital Compound,
Pokfulam, Hong Kong. Fax: +852 2855 1241.
E-mail address: hkumicro@hkucc.hku.hk (K.-Y. Yuen).
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doi:10.1016/j.virol.2007.08.010Other factors, such as cytosine deamination, which results in
C→U changes, have also been proposed to be responsible for
shaping the G+C contents and GC skews of RNAviruses (Pyrc
et al., 2004). Recently, it has been observed that codon usage is
an important driving force in the evolution of astroviruses and
small DNA viruses (Sewatanon et al., 2007; van Hemert et al.,
2007). Despite all these fragmented observations, no study has
integrated the various factors and been able to explain the basis
for codon usage bias in viruses successfully.
Coronaviruses are positive sense, single-stranded RNA
(ssRNA) viruses found in a wide range of animals in which
they can cause respiratory, enteric, hepatic and neurological
diseases of varying severity. The sizes of the genomes of corona-
viruses are about 30 kb, the largest among RNAviruses. Based on
genotypic and serological characterization, coronaviruses were
divided into three distinct groups (Brian and Baric, 2005; Lai and
Cavanagh, 1997; Ziebuhr, 2004). As a result of the low fidelity of
the RNA-dependent–RNA polymerases, the mutation rates of
RNA virus genomes are high, in the order of 1 per 10,000
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viral replication has resulted in a high frequency of recombina-
tion in coronaviruses (Lai and Cavanagh, 1997; Woo et al.,
2006b). Their tendency for recombination and high mutation
rates have made their genomes highly plastic, allowed them to
adapt to new hosts and ecological niches, and given them the
potential to be good candidates for causing pandemics. These
factors have made the study of coronavirus evolution particularly
important, both biologically and for practical purposes (Grigor-
iev, 2004; Gu et al., 2004; Yap et al., 2003). However, the relative
importance of the various selective forces that shape the codon
usage bias in coronaviruses and their underlying biological and
biochemical basis are still poorly understood.
The recent severe acute respiratory syndrome (SARS)
epidemic, the discovery of SARS coronavirus (SARS-CoV)
and identification of SARS-CoV-like viruses from Himalayan
palm civets and a raccoon dog from wild live markets in China
have led to a boost in interests in discovery of novel coronaviruses
in both humans and animals (Guan et al., 2003;Marra et al., 2003;
Peiris et al., 2003; Rota et al., 2003; Snijder et al., 2003; Woo et
al., 2004). For human coronaviruses, in 2004, a novel group 1
human coronavirus, human coronavirus NL63 (HCoV-NL63),
was reported (Fouchier et al., 2004; van der Hoek et al., 2004);
and in 2005, we described the discovery, complete genome
sequence andmolecular diversity of another novel group 2 human
coronavirus, coronavirus HKU1 (CoV-HKU1) (Lau et al., 2006;
Woo et al., 2005a,b,c, 2006b). As for animal coronaviruses, six
group 1 (Poon et al., 2005; Tang et al., 2006; Woo et al., 2006a;
Lau et al., 2007), six group 2, including bat SARS coronavirus,
sable antelope coronavirus, giraffe coronavirus, and two new
subgroups of group 2 coronaviruses (Lau et al., 2005; Li et al.,
2005; Woo et al., 2006a, 2007), 11 group 3 (Cavanagh et al.,
2002; East et al., 2004; Jonassen et al., 2005; Liu et al., 2005;
Hasoksuz et al., 2007) coronaviruses, and two unclassified
coronaviruses fromAsian leopard cats and Chinese ferret badgers
(Dong et al., 2007) have recently been described. Since the
number of coronavirus species with complete genomes available
has increased from 9 in 2003 to 19 in 2007, this has provided a
golden opportunity to study genome evolution in coronaviruses.
In this study, we analyzed the codon usage bias, dinucleotide
relative abundance, cytosine deamination in coronavirus
genomes and the codon usage bias in the hosts of the various
coronaviruses. The relative importance of the various forces in
shaping the codon usage bias in the various coronaviruses and
the extreme codon usage bias and cytosine deamination in CoV-
HKU1 were also discussed.
Results
Codon usage in coronavirus genomes
The mean (S.D.) effective number of codons (Nc) of the 19
coronaviruses is 45.448 (4.207) (Table 1). The codon usage
fractions in the 19 coronavirus genomes are shown in Table 2.
For all amino acids, the codon usage patterns of every individual
coronavirus species are similar to the general codon usage
patterns in coronaviruses. CoV-HKU1, HCoV-NL63, murinehepatitis virus (MHV) and bat coronavirus HKU5 (bat-CoV
HKU5) are the four coronaviruses with relatively larger number
of codons showing usage fractions outside the mean±2 S.D.
usage fraction range of the corresponding codons, probably due
to their relatively high (MHVand bat-CoV HKU5) or low (CoV-
HKU1 and HCoV-NL63) G+C contents (Tables 1 and 2).
To study the possible effect of CpG suppression on codon
usage bias, the usage fractions of the eight codons that contain
CpG (CCG, GCG, UCG, ACG, CGC, CGG, CGU and CGA)
were analyzed. Of these eight codons, six [CCG (mean 0.058),
GCG (mean 0.060), UCG (mean 0.038), ACG (mean 0.070),
CGG (mean 0.038) and CGA (mean 0.060)] were markedly
suppressed. CGC is slightly suppressed (mean 0.122) whereas
CGU is over-represented (mean 0.322).
To study the possible effect of cytosine deamination on codon
usage bias, codons of amino acids that can use C or U in the
codons were analyzed. For all amino acids that only use either
NNU or NNC as codon (asparagine, histidine, aspartic acid,
tyrosine, cysteine and phenylalanine), all NNU are markedly over
represented with usage fractions of more than 0.700, whereas the
usage fractions of all NNC are less than 0.300. For amino acids
that use NNU, NNC or other codons (threonine, isoleucine,
proline, leucine, alanine, glycine, valine and serine), the usage
fractions of all NNU are at least three times more than those of the
corresponding NNC. For leucine, UUA (mean 0.223) is used
much more frequently than CUA (mean 0.081), and UUG (mean
0.261) is used much more frequently than CUG (mean 0.072).
To study the possible effect of A↔G transition on codon
usage bias, codons of amino acids that can use A or G in the
codons were analyzed. For amino acids that use either NNA or
NNG as codons (lysine, glutamine and glutamic acid) and those
that use NNA, NNG or other codons but excluding those codons
with CpG (arginine, glycine and valine), the usage fractions of
NNA are often higher than those of NNG, but the differences
between the usage fractions of NNA and NNG are not as marked
as those between the usage fractions of NNU and NNC.
Codon usage in CoV-HKU1
Among all the 19 coronaviruses, CoV-HKU1 showed the
most extreme codon usage bias. CoV-HKU1 is the only
coronavirus that showed Nc outside the mean±2 S.D. range.
CoV-HKU1 also possessed the lowest G+C content, highest GC
skew, lowest percentages of G and C and highest percentage of U
among all coronavirus genomes (Table 1). For the six amino
acids that only use either NNU or NNC as codon (asparagine,
histidine, aspartic acid, tyrosine, cysteine and phenylalanine),
amino acids that use NNU, NNC or other codons (threonine,
isoleucine, proline, leucine, alanine, glycine, valine and serine),
and for leucine that use UNN or CNN as codon, the average (S.
D.) ratio of the usage fractions of the codons with U to those with
C is 9.66 (2.49) (Table 2). For amino acids that use either NNA
or NNG as codons (lysine, glutamine and glutamic acid) and
those that use NNA, NNG or other codons but excluding those
codons with CpG (arginine, glycine and valine), the average (S.
D.) ratio of the usage fractions of the codons with A to those with
G is 2.72 (0.57) (Table 2).
Table 1
Coronavirus genomes used in the present study
Coronavirus Host GenBank
accession
no.
Reference Genome
size
(bases)
G+C
content
(%)
GC
skew
Mononucleotide frequencies (%) Nc
G A U C
Group 1a
TGEV Pig NC_002306 Almazan et al., 2000 28,586 37.5 0.097 20.6 29.5 32.9 17.0 44.737
FIPV Cat AY994055 Haijema et al., 2003 29,355 38.1 0.102 21.0 29.2 32.7 17.1 46.150
PRCV Pig DQ811787 Zhang et al., 2007 27,550 37.4 0.107 20.7 29.3 33.2 16.7 44.406
Group 1b
HCoV-229E Human NC_002645 Thiel et al., 2001 27,317 38.2 0.129 21.6 27.2 34.6 16.7 44.281
HCoV-NL63 Human NC_005831 van der Hoek et al.,
2004
27,553 34.4 0.161 20.0 26.3 39.2 14.4 37.275
PEDV Pig NC_003436 Kocherhans et al.,
2001
28,033 42.0 0.086 22.8 24.7 33.2 19.2 48.424
BtCoV Bat DQ648858 Tang et al., 2006 28,203 40.1 0.102 22.1 26.2 33.7 18.0 46.905
Bat-CoV HKU2 Bat EF203064 Lau et al., 2007 27,164 38.9 0.140 22.2 24.9 35.1 16.8 43.342
Group 2a
HCoV-OC43 Human NC_005147 Vijgen et al., 2005 30,738 36.8 0.176 21.7 27.6 35.6 15.2 43.791
CoV-HKU1 Human NC_006577 Woo et al., 2005b 29,926 32.0 0.188 19.0 27.8 40.1 13.0 35.671
BCoV Cattle NC_003045 Chouljenko et al.,
2001
31,028 37.1 0.174 21.8 27.4 35.5 15.3 43.856
PHEV Pig NC_007732 Vijgen et al., 2006 30,480 37.2 0.164 21.7 27.3 35.4 15.6 44.380
MHV Mouse NC_001846 Leparc-Goffart et al.,
1997
31,357 41.7 0.142 23.9 26.0 32.3 17.9 51.237
Group 2b
SARS-CoV Human NC_004718 Marra et al., 2003 29,751 40.7 0.020 20.8 28.5 30.7 20.0 49.423
Bat-SARS-CoV
HKU3
Bat DQ022305 Lau et al., 2005 29,728 41.1 0.027 21.1 28.4 30.5 20.0 49.882
Group 2c
Bat-CoV HKU4 Bat EF065506 Woo et al., 2006b 30,286 37.8 0.093 20.7 27.6 34.6 17.1 44.585
Bat-CoV HKU5 Bat EF065511 Woo et al., 2006b 30,488 42.9 0.004 21.6 26.6 30.4 21.4 53.230
Group 2d
Bat-CoV HKU9 Bat EF065513 Woo et al., 2006b 29,114 41.0 0.138 23.3 25.3 33.7 17.7 46.162
Group 3
IBV Chicken NC_001451 Boursnell et al., 1987 27,608 37.9 0.144 21.7 28.9 33.2 16.2 45.777
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The codon usage fractions in the hosts of coronaviruses,
including human, mouse, pig, cat and chicken, are shown in
Table 3. To study the possible effect of CpG suppression on
codon usage bias, the usage fractions of the eight codons that
contain CpG (CCG, GCG, UCG, ACG, CGC, CGG, CGU and
CGA) were analyzed. Among these eight codons, six (CCG,
GCG, UCG, ACG, CGU and CGA) were suppressed, of which
five were also suppressed in the coronavirus genomes. To study
the possible effect of C↔U transition and A↔G transition on
codon usage bias, codons of amino acids that can use C or U and
those of amino acids that can use A or G in the codons were
analyzed. No pattern of difference was observed between the
use of NNU and NNC and between the use of NNA and NNG.
Dinucleotide relative abundance in coronavirus genomes
The relative abundance of the 16 dinucleotides in the 19
coronavirus genomes are shown in Table 4. Among the 16
dinucleotides, the relative abundance of CpG showed the most
marked deviation from the “normal range” (mean±S.D.=
0.509±0.063, 0.271 less than 0.78), with all 19 genomes
showing CpG under-representation. In addition, the relativeabundance of UpG and CpA also showed slight deviation from
the “normal range” (mean±S.D.=1.331±0.057 and 1.257±
0.070, respectively, both N1.23), with all 19 and 13 genomes
showing UpG and CpA over-representation, respectively.
Correlations between CpG suppression and cytosine
deamination in coronaviruses
The relationship between CpG suppression and cytosine
deamination in the 19 coronavirus genomes is shown in Fig. 1.
The mean (S.D.) of the NNU/NNC in the six amino acids that
only use either NNC or NNU as the codons of the 19 coronavirus
genomes is 3.262 (1.785). CoV-HKU1 showed extremely high
NNU/NNC ratio of 8.835. No significant correlation was
observed between CpG abundance and mean NNU/NNC ratio
in the 19 coronavirus genomes (r=−0.339, P =0.156).
Discussion
Marked CpG suppression is observed in all coronavirus
genomes. The discovery of Toll-like receptors (TLRs) that
recognize pathogen-associated molecular patterns and the
downstream molecular pathways was one of the biggest
advances in the understanding of vertebrate innate immunity
Table 2
Codon usage fractions in coronaviruses
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a Codons with CpG are in red and codons of amino acids that use either NNC or NNU as the codon are in green. (For interpretation of the references to colour in this table legend, the reader is referred to the
web version of this article.)
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Table 3
Codon usage fractions in different hosts of coronaviruses
a Codons with CpG are in red and codons of amino acids that use either NNC or NNU as the codon are in green. (For interpretation of the references to colour
in this table legend, the reader is referred to the web version of this article.)
436 P.C.Y. Woo et al. / Virology 369 (2007) 431–442in recent years. Among the TLR that recognize viral compo-
nents, TLR3, 7, 8 and 9 detect viral nucleic acids (Bowie and
Haga, 2005). It has been shown that TLR9 bound to CpG ofdouble-stranded DNA and elicited the downstream inflamma-
tory response, and administration of CpG oligodeoxynucleo-
tides has been shown to protect mice from herpes simplex virus 2
Table 4
Relative abundance of the 16 dinucleotides in the 19 coronavirus species with complete genomes available
a Numbers N1.23 and b0.78 are shown in red and green, respectively. (For interpretation of the references to colour in this table legend, the reader is referred
to the web version of this article.)
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it has been shown that CpG is under-represented in the genomes
of small DNAviruses, which could be related to their evasion of
the host immune systems (Karlin et al., 1994; Shackelton et al.,
2006). Although CpG suppression was also observed in RNA
viruses, no known TLR has been shown to recognize CpG of
ssRNA. However, recently it has been shown that ssRNA can
stimulate human CD14+CD11c+ monocytes to produce large
amounts of interleukin 12, but this activation of monocytes by
CpG oligoribonucleotides was not mediated through TLR3, 7, 8
or 9 (Sugiyama et al., 2005). The results suggested that CpG
oligoribonucleotides may stimulate monocytes through a novel
mechanism distinct from previously known immunostimulatory
nucleic acids. In the present study, we showed that themeanCpG
relative abundance in the coronavirus genomes is markedly
suppressed (Table 4). This concurs with the results observed in a
study on di- and trinucleotide frequencies in nine coronaviruses
10 years ago (Tobler and Ackermann, 1998). The most logical
way to avoid CpG is to mutate them to either UpG or CpA. This
is in line with the observation that these two dinucleotides are
over-represented in the coronavirus genomes, but their devia-
tions from the upper limit of the “normal range” is not as
remarkable as that of CpG from the lower limit of the “normal
range”, as the CpG suppression pressure is equally shared by
UpG and CpA over-representation. Interestingly, only CpG
containing codons in the context of purine-CpG (ACG and
GCG), pyrimidine-CpG (UCG and CCG) and CpG-purine
(CGA and CGG) are suppressed (Table 2), whereas CpG-
pyrimidine (CGU and CGC) are not. However, when trinucleo-
tide frequencies were analyzed in the 19 coronavirus genomes,
all the eight trinucleotides with CpG were suppressed (Fig. 2).
This indicates that there is probably another force that has led to
an increase use of CGU and CGC as codons for arginine, but this
force does not act on trinucleotides over the whole genome ingeneral. This force is probably unrelated to the relative
abundance of the corresponding tRNA molecules in the hosts
of the coronaviruses, as the pattern of bias in the hosts is not the
same as that in the coronaviruses.
In addition to CpG suppression, marked cytosine deamina-
tion is also observed in all coronavirus genomes. Although it has
been recognized that deamination of cytosine is a significant
source of spontaneous mutations for a few decades (Duncan and
Miller, 1980), DNA-cytosine deaminases, which are able to
attack cytosines in single-stranded DNA, have only been
discovered in the recent few years (Bransteitter et al., 2003;
Sohail et al., 2003). The discovery of the ability to edit human
immunodeficiency virus DNA, and subsequently RNA as well,
by the human cytidine deaminase APOBEC3G has allowed the
speculation that APOBEC-mediated cytosine deamination may
contribute to the sequence variation of RNA viruses that
replicate without any DNA intermediates (Bishop et al., 2004).
GC skew, which reflects cytosine deamination, has been studied
in various coronaviruses, and it has been shown that the GC
skews of coronavirus genomes become less pronounced in the
one third of the genome that encodes the structural proteins
(Grigoriev, 2004; Pyrc et al., 2004). In the present study, using
the six amino acids that are only encoded by NNU or NNC,
hence excluding most other pressures that may affect the relative
abundance of cytosine and uracil, we showed that all these NNU
and NNC had usage fractions of N0.700 and b0.300, res-
pectively (Table 2). In fact, for all codons that encode the same
amino acid and with either C or U in any position, the usage
fraction of the codon that uses U is invariably higher than the one
that uses C in all coronaviruses. Furthermore, the percentage of
C showed strong inverse relationships with the percentage of U
in coronavirus genomes (r=−0.902, Pb0.0001) (Fig. 3). All
these suggest that cytosine deamination is an important
biochemical force in shaping coronavirus evolution.
Fig. 1. Correlation between CpG dinucleotide abundance and NNU/NNC ratio in the 19 coronavirus genomes.
438 P.C.Y. Woo et al. / Virology 369 (2007) 431–442Cytosine deamination and selection of CpG suppressed
clones by the immune system are the two major independent
biochemical and biological selective forces that shape codon
usage bias in coronavirus genomes. Codon usage bias in
coronaviruses is unrelated to the relative abundance of the
corresponding tRNA molecules, as the patterns of bias in
codon usage fractions in the hosts are not the same as those in
the coronaviruses (Tables 2 and 3). Although others have tried
to explain variations in codon usage in coronaviruses by
compositional constraints (Gu et al., 2004), we think that both
codon usage bias and nucleotide composition of the corona-
virus genomes, which are apparently related to each other, are
both results of other biological and biochemical selective
forces, rather than nucleotide composition as a cause of codon
usage bias. On the other hand, most of the codon usage bias in
the coronaviruses can be easily explained by CpG suppression
and cytosine deamination (Table 2). For asparagine, isoleucine,
histidine, aspartic acid, glycine, valine, tyrosine, cysteine and
phenylalanine, NNU are used more frequently than NNCFig. 2. Mean frequencies of 64 trinucleotides in the 19 coronavirus genomes. The dots
the trinucleotides. The dotted line represents the frequency of each trinucleotide (
trinucleotides are in red.because of cytosine deamination. For lysine, glutamine and
glutamic acid, NNA are used slightly more frequently than
NNG because of cytosine deamination in the minus strand
during RNA replication. For threonine, ACG is suppressed
because of CpG suppression and ACU is used more frequently
than ACC because of cytosine deamination. For arginine, CGA
and CGG are suppressed because of CpG suppression and
CGU is used more frequently than CGC because of cytosine
deamination. AGA is used more frequently than AGG and
CGA is used more frequently than CGG because of cytosine
deamination in the minus strand during RNA replication. For
proline, CCG is suppressed because of CpG suppression and
CCU is used more frequently than CCC because of cytosine
deamination. For leucine, CUU is used more frequently than
CUC, UUA is used more frequently than CUA, and UUG is
used more frequently than CUG because of cytosine deamina-
tion. For alanine, GCG is suppressed because of CpG
suppression and GCU is used more frequently than GCC
because of cytosine deamination. For serine, UCG isand the bars represent the mean frequencies and the 95% confidence intervals of
1/64=0.015625) if the bases are distributed in random. The CpG containing
Fig. 3. Correlations among mononucleotide frequencies in the 19 coronavirus genomes. The symbols for the various coronaviruses are the same as those used in Fig. 1.
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frequently than UCC while ACU is used more frequently than
ACC because of cytosine deamination. In addition to showing
that CpG suppression and cytosine deamination are probably
the two most important biological/biochemical forces that
shape codon usage bias, we also demonstrated that these two
forces are independent (Fig. 1), although cytosine deamination
and subsequent selection of CpG suppressed clones by the
immune system may be one of the mechanisms that has led to
the resultant CpG suppression. Furthermore, we speculate that
the species-specific number of CpG containing codons may not
simply be the result of mutation pressure to avoid CpG, but an
equilibrium between the immune pressure and the required
number of CpG containing codons to serve biological
functions such as to maintain RNA structure stability. Such
an additional factor could explain the mere correlation between
the NNU/NNC ratio and CpG dinucleotide abundance.
The underlying mechanism for the extreme codon usage
bias, cytosine deamination and G+C content in CoV-HKU1 is
enigmatic. The contribution of cytosine deamination to genomeevolution varies from very low to very high among the 19
coronavirus genomes. For bat-CoV HKU5, SARS-CoVand bat-
SARS-CoV, the mean NNU/NNC ratios are less than 1.7 (Fig.
1). Codon usage bias in these coronaviruses is relatively mild
(Nc of 53.23, 49.423 and 49.882, respectively; Table 1), and is
mainly due to CpG suppression (Table 2). On the other hand, for
CoV-HKU1, the mean NNU/NNC ratio is more than 8.8 (Fig.
1), which is likely a result of rapid cytosine deamination.
Although the biochemical basis for this extreme cytosine
deamination is not known, this is probably the explanation for
the extremely strong codon usage bias in CoV-HKU1 (Nc of
35.671) and its lowest G+C content of 32% among all
coronavirus genomes (Table 1).
Materials and methods
Coronavirus and host genomes
One genome sequence of each of the 19 coronavirus species
with complete genome sequence available was downloaded
440 P.C.Y. Woo et al. / Virology 369 (2007) 431–442from the GenBank database (Table 1). The genomes of the hosts
of the coronaviruses, including those of human, mouse, pig, cat
and chicken, were also downloaded.
Codon usage
Codon usage bias was calculated according to the method
described by Wright (1990). Using this method, when only one
codon is used for each amino acid, Nc for the virus would be 20,
and when all codons are used equally, the Nc for the virus would
be 61. The codon usage fraction of a particular codon in a
genome is calculated by the ratio of the number of that codon to
the number of the amino acid that codon and other synonymous
codons encode for in the protein coding sequence of the
genome. The method for calculating codon usage bias
accounting for background nucleotide composition (Nc′)
(Novembre, 2002) was not used because it had been proposed
to suffer from methodology problems, although those problems
did not affect the conclusions which had been drawn by using
Nc of this study (Fuglsang, 2006).
Dinucleotide relative abundance in coronavirus genomes
The relative abundance of the dinucleotides in the corona-
virus genomes was assessed using the method described by
Karlin and Burge (1995). The odds ratio ρxy= fxy/fxfy, where fx
denotes the frequency of the nucleotide X and fxy the frequency
of the dinucleotide XY, etc., for each dinucleotide were
calculated. From data simulations and statistical theory,
ρxy≤0.78 (extreme under-representation) or ρxy≥1.23 (ex-
treme over-representation) occurs for sufficiently long (≥20 kb)
random sequences with the probability at most 0.001 for
virtually any base composition.
Correlations between CpG suppression and cytosine
deamination in coronaviruses
To study possible correlations between CpG suppression and
cytosine deamination in coronaviruses, the relative abundance
of CpG and the mean ratio of NNC to NNU in the six amino
acids (asparagine, histidine, aspartic acid, tyrosine, cysteine and
phenylalanine) that only use either NNC or NNU as the codons
(NNU/NNC ratio, representing contribution of cytosine deami-
nation) were calculated for all 19 coronavirus genomes.
Analysis of correlation between CpG deamination and NNU/
NNC ratio was performed using Pearson's correlation (SPSS
version 11.0).
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